Document Type : Case reports


1 Department of Infectious Disease, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.

2 Department of ICU, Luzhou People's Hospital, Luzhou, Sichuan 646000, China.

3 Department of Pediatric Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.

4 Department of Medical Administration, Luzhou People's Hospital, Luzhou, Sichuan 646000, China

5 Department of Infectious Disease, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China


Introduction: Since December 2019, a new type of pneumonia named coronavirus disease 2019 (COVID-19) has been reported in Wuhan, Hubei province, China. At present, there are no relevant reports on cases of COVID-19 and comorbid pulmonary tuberculosis. We herein report a case of a patient with COVID-19 and comorbid pulmonary tuberculosis.
Case Presentation: A 47-year-old female patient with COVID-19 positive pharyngeal swabs. She did not have fever, coughing or breathing difficulties. The patient diagnosed as COVID-19, and pulmonary tuberculosis based on the patient's epidemiological history, routine blood test, imaging findings, and COVID-19 nucleic acid test results. Contact and droplet precautions were implemented. Antiviral treatment, anti-tuberculosis treatment, and liver protection treatment were given. The patient has not complained of discomfort, and her condition is stable.
Conclusions: COVID-19 and comorbid tuberculosis is suspected, epidemiological history, clinical presentation, laboratory tests, and imaging examinations must be combined to make a comprehensive diagnosis and prompt quarantine and treatment measures should be implemented.


  1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. doi: 10.1016/S0140-6736(20)30211-7. [PubMed: 32007143].
  2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. doi: 10.1056/NEJMoa2001017. [PubMed: 31978945].
  3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. [PubMed: 31986264].
  4. Shi HS, Han XY, Fan YQ, Liang B, Yang F, Han P, et al. Clinical characteristics and imaging presentation of novel coronavirus (2019-nCoV) pneumonia. J Clin Radiol. 2020;In Press. doi: 10.13437/j.cnki.jcr.20200206.002.
  5. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):200045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045. [PubMed: 31992387].
  6. Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4. doi: 10.1186/s40779-020-0233-6. [PubMed: 32029004].
  7. Liu QY, Wang XL. Targeted drug research strategy for novel coronavirus (2019-nCoV). Acta Pharm Sin. 2020;55(02):181-8. doi: 10.16438/j.0513-4870.2020-0106.
  8. Li H, Tan XC, Jiang D, Hao YM, Zhang YJ, Fang XQ, et al. Research progress on coronavirus and drugs for treatment. Chin Pharm J. 2020;In Press.
  9. Chen W, Zhang CY, Zhu Y, Zhang YH, You LB, Wu BS, et al. Comparison of viral nucleic acid detection in throat swabs and sputum samples from 4 cases of new coronavirus infection. Chin J Zoonoses. 2020;In Press.